期刊文献+

含左氧氟沙星四联幽门螺杆菌补救治疗方案的疗效观察 被引量:4

Effective observation of the levofloxacin-based quadruple rescue therapy regimen in eradicating H. pylori
下载PDF
导出
摘要 目的研究含左氧氟沙星的四联幽门螺杆菌补救治疗方案的疗效及安全性,探讨治疗幽门螺杆菌感染的安全、有效方案。方法选择消化性溃疡及慢性胃炎幽门螺杆菌感染患者进行过1次或多次H.pylori根除治疗、停用抗生素至少1个月、停用质子泵抑制剂至少2周、复查14C尿素呼气试验仍为阳性者41例,口服兰索拉唑,枸橼酸铋钾,左氧氟沙星,呋喃唑酮。观察其根除率、不良反应、症状缓解及溃疡愈合情况。结果41例患者中失访4例,幽门螺杆菌根除32例,意向性治疗分析根治率78.0%,符合方案治疗分析根除率86.5%;症状改善总有效率91.9%;不良反应发生率16.2%,无严重不良反应。结论含左氧氟沙星四联补救治疗方案是一安全有效治疗方法。 Objective Study of the levofloxacin - based quadruple rescue therapy was to discuss safe and effective. Methods Forty - one patients who had H. pylori eradication one or more times with chronic gastritis or peptic ulcer, stopping antibiotic at least one month, and PPI at least two weeks, but recent^14 C-Urea breath test (UBT) was still positive, were treated with the regimen: levofloxacin, furazolidone, bismuth potassium citrate, and lansoprazole for 7 days, The eradication rates, efficacy, and adverse reaction rates of the three regimens were observed. Results Eradication rates by intention -to -treat and per - protocol analyses were 78.0% and 86.5%, respectively. The total release rate of all symptoms was 91.9%. adverse reaction were slight and the adverse reaction rate was 16.2%. Conclusions The levofloxacin -based quadruple rescue therapy regimen was safe and effective.
出处 《临床药物治疗杂志》 2009年第4期22-25,44,共5页 Clinical Medication Journal
关键词 幽门螺杆菌 补救治疗 左氧氟沙星 Helicobacter pylori rescue therapy levofloxacin
  • 相关文献

参考文献12

二级参考文献112

  • 1萧树东.幽门螺杆菌的基础与临床研究[J].现代消化及介入诊疗,2003,8(3):136-137. 被引量:16
  • 2张万岱,胡伏莲,袁耀宗,徐智民,吴云林,程天明,牟方宏,魏红,孙菁,陈学清.瑞贝克三联一周疗法根除幽门螺杆菌的临床研究[J].现代消化及介入诊疗,2003,8(3):158-159. 被引量:9
  • 3黄跃,许鲁宁.环丙沙星一周疗法根除幽门螺杆菌[J].中国新药杂志,1994,3(2):34-36. 被引量:10
  • 4王震华,熊光苏,吴叔明.含左氧氟沙星的四联方案补救治疗幽门螺杆菌的临床研究[J].胃肠病学和肝病学杂志,2006,15(1):38-39. 被引量:31
  • 5UEMEURA N, OKAMOTO S, MUKAI T, et al. Effect of Helicobacter pylori eradication on the healing and recurrence of pepcic ulcer: combination therapy with low-dose omeprazole and clarithroimycin[J]. Eur J Gastroenterol Hepatol, 1995,7 ( Suppl1) :67-89.
  • 6AVERY G, DANGERUTA K, GARY S, et al. Metronidazole resistance in Helicobacter pylori is due to null mutations in agene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase[J]. Mol Microbiol,1998,28 (2) :383 393.
  • 7CHIBA N, MARSHALL C P. Omeprazole once or twice daily with clarithroimycin and metronidazole for helicobacter pylori[J]. Can J Gastroenterol, 2000, 14 (1) : 27-31.
  • 8CAMMAROTA G, CIANCI R, CANNIZZARO O. High-dose versus low-dose clarithromycin in 1-week triple therapy,including rabeprazole and levofloxacin, for Helicobacter pylori eradication[J]. J Clin Gastroenterology, 2004,38 (2) : 110-114.
  • 9Van der Hulst RW, Rauws EA, Koycu B, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology, 1997, 113: 1082-1086.
  • 10Malfertheiner P, Bayerdorffer E, Diete U, et al. The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther, 1999, 13: 703-712.

共引文献336

同被引文献38

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部